Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Lentivirus administration to rat muscle provides efficient sustained expression of erythropoietin|
|Citation:||Blood, 2001; 98(3):594-596|
|Publisher:||Amer Soc Hematology|
|Jurgen Seppen, Simon C. Barry, Brandon Harder, and William R. A. Osborne|
|Abstract:||A lentivirus pseudotyped with vesicular stomatitis virus G protein (VSV-G) encoding rat erythropoietin (EPO) complementary DNA was administered to rat skeletal muscle and red blood cell production was serially monitored. After a single intramuscular injection hematocrit values increased and reached a plateau at about 35 days and were sustained for at least 14 months. Virus doses of 6 x 10(7) infectious units and 6 x 10(6) infectious units produced significantly increased mean hematocrit values of 68.5% +/- 2.1% (P <.001, n = 4) and 52.7% +/- 1.3% (P <.001, n = 3), respectively, over values of control animals receiving normal saline (46.2% +/- 1.5%, n = 2). A polymerase chain reaction (PCR) assay for vector sequences in genomic DNA showed muscle tissue at the site of injection was positive and undetectable in liver, spleen, kidney, and lung. The intramuscular administration of lentivirus provided a dose-responsive, highly efficient and sustained EPO gene delivery, suggesting these vectors may be applied generally to the systemic delivery of proteins such as hormones and clotting factors. (Blood. 2001;98:594-596)|
|Keywords:||Animals; Rats, Inbred F344; Rats; Lentivirus; Hemoglobins; Erythropoietin; Leukocyte Count; Platelet Count; Hematocrit; Injections, Intramuscular; Genetic Vectors; Time Factors; Genetic Therapy|
|Rights:||© 2001 by The American Society of Hematology.|
|Appears in Collections:||Paediatrics publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.